![Bengt-Harald Jonsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bengt-Harald Jonsson
Corporate Officer/Principal at University of Linköping
Profile
Bengt-Harald Jonsson is currently a Professor of Molecular Biotechnology at the University of Linköping.
He previously worked as a Director at ModPro AB.
Bengt-Harald Jonsson active positions
Companies | Position | Start |
---|---|---|
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | 30/10/2009 |
Former positions of Bengt-Harald Jonsson
Companies | Position | End |
---|---|---|
ModPro AB
![]() ModPro AB Medical SpecialtiesHealth Technology ModPro AB is a holding company that develops novel proprietary concept for recognition and binding of proteins in vitro and in vivo. It is a biopharmaceutical company that designs and produces synthetic binders for proteins for applications in diagnostics, drug development, molecular imaging, and for protein purification. Its technology combines small organic molecules, or "hot spot" mimics with polypeptides from a designed set to form powerful binders for proteins. Its concept is unprecedented and analogous with protein surfaces involved in protein-protein interactions. The company was founded by Lars Harald Baltzer in 2002 and is headquartered in Uppsala, Sweden. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
ModPro AB
![]() ModPro AB Medical SpecialtiesHealth Technology ModPro AB is a holding company that develops novel proprietary concept for recognition and binding of proteins in vitro and in vivo. It is a biopharmaceutical company that designs and produces synthetic binders for proteins for applications in diagnostics, drug development, molecular imaging, and for protein purification. Its technology combines small organic molecules, or "hot spot" mimics with polypeptides from a designed set to form powerful binders for proteins. Its concept is unprecedented and analogous with protein surfaces involved in protein-protein interactions. The company was founded by Lars Harald Baltzer in 2002 and is headquartered in Uppsala, Sweden. | Health Technology |
- Stock Market
- Insiders
- Bengt-Harald Jonsson